Q3 FY2025 · Press release
BridgeBio-Reports-Positive-Phase-3-Topline-Results-for-Encaleret-in-Patients-with-Autosomal-Dominant-Hypocalcemia-Type-1-2025 (1) · October 29, 2025 · 5 pages
Read BridgeBio Pharma, Inc.'s results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional